logo
Plus   Neg
Share
Email

United Fire Group Slips To Loss In Q4 - Quick Facts

United Fire Group, Inc. (UFCS) on Wednesday reported that its fourth-quarter consolidated net loss, including net realized investment gains and losses, was $29.34 million or $1.17 per share, compared to consolidated net income of $45.99 million or $1.81 per share in the same period in 2017.

The company recognized net realized investment losses from continuing operations of $27.6 million in the quarter, compared to net realized investment gains of $0.7 million in the prior-year quarter.

The change in net realized investment gains and losses for the quarter compared to the same period in 2017 was primarily due to a decrease of $27.6 million in the fair value of the company's equity securities investments.

Consolidated adjusted operating loss for the quarter was $0.30 per share, compared to consolidated adjusted operating income of $1.78 per share in the year-ago period.

Total revenues for the quarter declined 16.5 percent to $252.06 million from $301.74 million a year ago.

On average, analysts polled by Thomson Reuters expected the company to report earnings of $0.23 per share for the quarter. Analysts' estimates typically exclude special items.

Net premiums written rose 1.2 percent to $253.55 million from $250.46 million in the same period last year.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
J. M. Smucker Co. is recalling certain Natural Balance canned cat food, citing health concerns likely associated with increased levels of choline chloride, an animal growth promotant, the U.S. Food and Drug Administration said in a statement. The recall was initiated after receiving reports of adverse reactions. Polaris Industries Inc. is recalling certain Ranger and General Utility, as well as All-Terrain vehicles citing risks of crash, the U.S. Consumer Product Safety Commission said in a statement. The Medina, Minnesota-based company has called back about 26,730 units of Model Year 2019 - 2020 Ranger XP 1000 & Model Year 2020 General XP 1000 Utility vehicles. Gilead Sciences Inc. (GILD) said Friday that the European Commission has granted conditional marketing authorization for Veklury or remdesivir as a treatment for SARS-CoV-2 infection, the virus that causes COVID-19.
Follow RTT